Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06537310
PHASE1

A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors

Sponsor: Hoffmann-La Roche

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD) and preliminary clinical activity of RO7567132 as single agent and in combination with atezolizumab. The study will enroll adult participants with selected locally advanced and/or metastatic solid tumors for whom standard therapy does not exist, or has proven to be ineffective or intolerable.

Official title: An Open-label, Multicenter, Dose-escalation, Randomized, Phase I Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Anti-Tumor Activity of RO7567132, as a Single Agent and in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

34

Start Date

2024-09-16

Completion Date

2027-08-10

Last Updated

2026-03-03

Healthy Volunteers

No

Interventions

DRUG

RO7567132 and Atezolizumab

RO7567132 will be administered either as monotherapy or in combination with atezolizumab at a dose and schedule as specified for the respective cohort.

DRUG

RO7567132 and Atezolizumab

RO7567132 will be administered in combination with atezolizumab at a dose and schedule as specified for the respective cohort.

Locations (11)

Kinghorn Cancer Centre

Darlinghurst, New South Wales, Australia

Austin Health

Heidelberg, Victoria, Australia

UZ Leuven Gasthuisberg

Leuven, Belgium

BC Cancer ? Vancouver

Vancouver, British Columbia, Canada

Princess Margaret Cancer Center

Toronto, Ontario, Canada

McGill University Health Center

Montreal, Quebec, Canada

Rigshospitalet

København Ø, Denmark

Clinica Universidad de Navarra

Pamplona, Navarre, Spain

Vall d?Hebron Institute of Oncology (VHIO), Barcelona

Barcelona, Spain

Clinica Universidad de Navarra Madrid

Madrid, Spain

Fundacion Jimenez Diaz

Madrid, Spain